Indications for Use: Treatment of novel coronavirus infection (COVID-19), confirmed by diagnostic testing for SARS-CoV-2, with mild to moderate disease severity in adult patients at high risk for progression to severe disease, who do not require supplemental oxygen therapy.

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the medical instruction for Molnupiravir PSK, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx